ATHIRA PHARMA INC. - COMMON STOCK
0.4443
27-9月-24 15:59:55
15 分の遅延
株式
+0.0257
+6.14%
本日の幅
0.4250 - 0.4465
ISIN
N/A
ソース
NASDAQ
-
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
17 9 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
03 9 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
01 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
09 7 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
12 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
11 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming June Conferences
29 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
17 5 2024 17:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
15 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming May Conferences
02 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
15 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
11 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
03 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
22 2 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
08 2 2024 16:02:00 提供 Nasdaq GlobeNewswire
-
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
08 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
03 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
12 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >